FeirenSangza (Talk | contribs) |
FeirenSangza (Talk | contribs) |
||
Line 160: | Line 160: | ||
<img src="https://static.igem.org/mediawiki/2017/1/1c/Sfls-achi-silver.svg"> | <img src="https://static.igem.org/mediawiki/2017/1/1c/Sfls-achi-silver.svg"> | ||
<li> We proved that our central part <a href="http://parts.igem.org/Part:BBa_K2200010">BBa_K2200010 </a> worked as expected and submitted the part tothe iGEM Parts Registry.</li> | <li> We proved that our central part <a href="http://parts.igem.org/Part:BBa_K2200010">BBa_K2200010 </a> worked as expected and submitted the part tothe iGEM Parts Registry.</li> | ||
− | <li> We made lots of <a href="https://2017.igem.org/Team:Shenzhen_SFLS/ | + | <li> We made lots of <a href="https://2017.igem.org/Team:Shenzhen_SFLS/Collaborations "> Collaborations </a> with other teams!</li> |
<li>We enhanced the public attention toward skin cancer and dealt with the public misunderstanding toward genetic therapy and diseases. More details for <a href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver">silver HP </a>. </li> | <li>We enhanced the public attention toward skin cancer and dealt with the public misunderstanding toward genetic therapy and diseases. More details for <a href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver">silver HP </a>. </li> | ||
Revision as of 03:42, 2 November 2017
MEDAL CRITERIA
BRONZE
SILVER
GOLD
AWARDS